VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Colby who wrote (9659)	6/15/1998 7:39:00 PM
From: VLAD	Read Replies (2) of 23519

Colby, In your calculation of product sold you need to multiple the weekly number by 6 doses per script. So far this Q IMS reports a total of 73,554 scripts 73,554/10 weeks = 7,355 average this quarter so far. 7,355/.6 = 12,259 actual average scripts per week. From the looks of things most sales this quarter are from satisfied customers so most new scripts are probably just old customers who have run out of refills. 12,258 X 6 doses/script = 73,554 doses per week 73,554 x 13 weeks = 956,202 doses sold in the US this quarter. So about 1/2 of the 1.8 million units is sold here and the rest is shipped for sales in England and some of the new countries. This seems about right. England has been using a good deal of MUSE since it's launch. the numbers seem to confirm that currently Vivus is able to sell 1.8 million units per quarter. Anybody care to correct me?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next